Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma
| dc.contributor.author | Voorham, Jaco | |
| dc.contributor.author | Xu, Xiao | |
| dc.contributor.author | Price, David B. | |
| dc.contributor.author | Golam, Sarowar | |
| dc.contributor.author | Davis, Jill | |
| dc.contributor.author | Zhi Jie Ling, Joanna | |
| dc.contributor.author | Kerkhof, Marjan | |
| dc.contributor.author | Ow, Mandy | |
| dc.contributor.author | Tran, Trung N. | |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en | 
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en | 
| dc.date.accessioned | 2018-12-12T05:22:11Z | |
| dc.date.available | 2018-12-12T05:22:11Z | |
| dc.date.issued | 2019-02 | |
| dc.description | Editorial support was provided by Mike Jaqua, PhD, and AlanSaltzman, PhD, of JK Associates, Inc., and Michael A. Nissen, ELS, ofAstraZeneca. This support was funded by AstraZeneca. | en | 
| dc.description.status | Peer reviewed | en | 
| dc.format.extent | 11 | |
| dc.format.extent | 735671 | |
| dc.identifier | 141083642 | |
| dc.identifier | 60505d1b-3b0a-4a9b-910c-68da326c3ace | |
| dc.identifier | 85056783636 | |
| dc.identifier.citation | Voorham, J, Xu, X, Price, D B, Golam, S, Davis, J, Zhi Jie Ling, J, Kerkhof, M, Ow, M & Tran, T N 2019, 'Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma', Allergy, vol. 74, no. 2, pp. 273-283. https://doi.org/10.1111/all.13556 | en | 
| dc.identifier.doi | 10.1111/all.13556 | |
| dc.identifier.iss | 2 | en | 
| dc.identifier.issn | 0105-4538 | |
| dc.identifier.other | RIS: urn:58911B552FDD5DF441E4FC2A0CC8CE01 | |
| dc.identifier.other | Mendeley: 6a6b662b-829d-3a54-a9ed-141b96ff4e9b | |
| dc.identifier.uri | http://hdl.handle.net/2164/11606 | |
| dc.identifier.url | http://www.mendeley.com/research/healthcare-resource-utilization-costs-associated-incremental-systemic-corticosteroid-exposure-asthma | en | 
| dc.identifier.vol | 74 | en | 
| dc.language.iso | eng | |
| dc.relation.ispartof | Allergy | en | 
| dc.subject | SDG 3 - Good Health and Well-being | en | 
| dc.subject | adverse outcomes | en | 
| dc.subject | asthma | en | 
| dc.subject | healthcare costs | en | 
| dc.subject | healthcare resource utilization | en | 
| dc.subject | systemic corticosteroids | en | 
| dc.subject | R Medicine (General) | en | 
| dc.subject | Supplementary Data | en | 
| dc.subject.lcc | R1 | en | 
| dc.title | Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma | en | 
| dc.type | Journal article | en | 
Files
Original bundle
1 - 1 of 1
- Name:
- Healthcare_resource_utilization_and_costs_associated_with_incremental_systemic_corticosteroid_exposure_in_asthma.pdf
- Size:
- 718.43 KB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
